Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stem Cell Infusion”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07512362
What this trial is testing

Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.

Who this might be right for
Mild Cognitive ImpairmentEarly Alzheimer's DiseaseAD-MCI
Bernard (Barry) Baumel 10
Early research (Phase 1)Study completedNCT02625246
What this trial is testing

Safety and Potential Efficacy of Human Mesenchymal Stem Cells in Non-Cystic Fibrosis Bronchiectasis

Who this might be right for
Bronchiectasis
Marilyn Glassberg 6
Testing effectiveness (Phase 2)Looking for participantsNCT07127289
What this trial is testing

Autologous Hematopoietic Stem Cell Infusion for Prolonged Cytopenia After CAR-T Cell Therapy

Who this might be right for
Prolonged Cytopenia Following CAR-T Therapy
Institute of Hematology & Blood Diseases Hospital, China 20
Large-scale testing (Phase 3)UnknownNCT03662087
What this trial is testing

HMA+DLI vs DLI Preemptive Therapy Based on MRD for AL Undergoing Allo-HSCT

Who this might be right for
Minimal Residual Disease,Acute Leukemia, Hypomethylating Agents, Donor Lymphocyte Infusion, Allogeneic Hematopoietic Cell Transplantation
Nanfang Hospital, Southern Medical University 100
Early research (Phase 1)Ended earlyNCT04310592
What this trial is testing

Natural Killer Cell (CYNK-001) Infusions in Adults with AML

Who this might be right for
LeukemiaLeukemia, MyeloidLeukemia, Myeloid, Acute+17 more
Celularity Incorporated 27
Testing effectiveness (Phase 2)Study completedNCT01538472
What this trial is testing

Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00303667
What this trial is testing

Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Myelogenous Leukemia
Masonic Cancer Center, University of Minnesota 50
Testing effectiveness (Phase 2)Ended earlyNCT01337544
What this trial is testing

Haploidentical Stem Cell Transplantation and IL-15 NK Cell Infusion for Paediatric Refractory Solid Tumours

Who this might be right for
Childhood Solid Tumor
Hospital Infantil Universitario Niño Jesús, Madrid, Spain 6
Testing effectiveness (Phase 2)Ended earlyNCT03537599
What this trial is testing

Daratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell Transplant

Who this might be right for
Minimal Residual DiseaseRecurrent Acute Myeloid Leukemia With Myelodysplasia-Related ChangesRecurrent Adult Acute Myeloid Leukemia+1 more
Sumithira Vasu 4
Testing effectiveness (Phase 2)Study completedNCT00005801
What this trial is testing

Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
University of Colorado, Denver
Testing effectiveness (Phase 2)Study completedNCT03691909
What this trial is testing

Phase 1/2a Clinical Trial to Assess the Safety of HB-adMSCs for the Treatment of Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hope Biosciences LLC 15
Testing effectiveness (Phase 2)Study completedNCT02933827
What this trial is testing

Adipose-derived Stem Cells (ADSCs) for Moderate to Severe Chronic Kidney Disease

Who this might be right for
Moderate to Severe Chronic Kidney Disease
UnicoCell Biomed CO. LTD 39
Testing effectiveness (Phase 2)Study completedNCT00535197
What this trial is testing

Autologous Bone Marrow Stem Cells in Ischemic Stroke.

Who this might be right for
Stroke, AcuteInfarction, Middle Cerebral Artery
Imperial College London 5
Testing effectiveness (Phase 2)Ended earlyNCT00497926
What this trial is testing

Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion

Who this might be right for
Kidney Failure
Talaris Therapeutics Inc. 37
Early research (Phase 1)Study completedNCT00474461
What this trial is testing

Cardiac Stem Cell Infusion in Patients With Ischemic CardiOmyopathy (SCIPIO)

Who this might be right for
Coronary Artery DiseaseCongestive Heart Failure
University of Louisville 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07769671
What this trial is testing

Human Umbilical Cord Mesenchymal Stem Cell Infusion for Type 2 Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy Type 2
The First People's Hospital of Changzhou 49
Testing effectiveness (Phase 2)Study completedNCT00003553
What this trial is testing

Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
National Heart, Lung, and Blood Institute (NHLBI) 156
Testing effectiveness (Phase 2)Study completedNCT03169231
What this trial is testing

Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty

Who this might be right for
Aging Frailty
Longeveron Inc. 150
Early research (Phase 1)UnknownNCT06518902
What this trial is testing

Umbilical Cord-derived Mesenchymal Stem Cell Infusion for Treating Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
National Engineering Center of Cell Products 18
Early research (Phase 1)Study completedNCT01853358
What this trial is testing

Phase I of Infusion of Selected Donor NK Cells After Allogeneic Stem Cell Transplantation

Who this might be right for
Hematological Malignancy
Institut Paoli-Calmettes 17
Next Page